百普赛斯

301080 SZSE 证监会行业分类 M73研究和试验发展

Key Metrics

Market Cap

6.9B ($1.0B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

645.0M

Net Income

120.0M

Gross Margin

N/A

Op. Margin

19.4%

Net Margin

18.6%

ROE

4.6%

ROA

4.1%

D/E

0.12

Dividend Yield

N/A

EPS

1.03

Current Ratio

8.01

Price History

Company Info

Industry	M73研究和试验发展
Market Segment	ChiNext
Currency	CNY
Fiscal Year	2024

Business Overview

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 百普赛斯

Ticker	301080
Exchange	SZSE
Sector	证监会行业分类
Industry	M73研究和试验发展